オルガノイドとスフェロイドの市場規模、シェア、動向分析レポート：タイプ別、用途別、最終用途別、地域別、セグメント別予測、2024年～2030年

オルガノイドとスフェロイド市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界のオルガノイドとスフェロイド市場規模は、予測期間中にCAGR 23.11％を記録し、2030年までに32億6,000万米ドルに達すると予測されています。

創薬におけるオルガノイド培養の採用の増加、および世界全体での細胞療法と組織工学の需要の高まりが、市場を牽引すると予測されています。

3Dスフェロイドは、複雑な組織や臓器を生成するためのビルディングブロックとして使用できるため、組織工学や再生医療研究の重要な側面と考えられています。加えて、3D細胞培養は薬剤スクリーニングやヒト疾患の分析モデルとして使用できる可能性があり、近い将来、市場に十分な成長機会をもたらすと期待されています。

ヒト特有の疾患のメカニズム評価にオルガノイド培養を採用する動きが活発化しており、市場の成長が期待されます。例えば、ヒトオルガノイドは小腸、前立腺、脳、肝臓など幅広い組織の分析に役立っています。ヒト臓器に類似した3D細胞培養の生成は、細胞療法としてのオルガノイドの使用や、全臓器移植の代替品としての可能性に大きな可能性をもたらしています。

オルガノイドとスフェロイド市場レポート・ハイライト

• スフェロイドセグメントは、分析期間を通じて市場を独占すると予測されます。
• 創薬、疾患モデリング、安全性試験の分野で3Dスフェロイドの採用が増加していることが、同分野を牽引する主要因となっています。
• 人工多能性幹細胞（iPSC）からのオルガノイドの開発は、細胞発生の動的観察への道を開き、ヒト発生のメカニズム研究の採用を推進したため、発生生物学アプリケーションセグメントは2023年に最大の収益シェアを占めました。
• 2023年の市場では、バイオテクノロジーと製薬業界が最終用途セグメントを独占しました。これは、製薬企業による前臨床創薬でのオルガノイドやスフェロイドの利用率が高いためです。
• さらに、これらの企業は、オルガノイドやスフェロイドの生成効率を高める先進的な製品の開発に積極的に取り組んでいます。
• 北米では、技術的に先進的な細胞培養プラットフォームの採用率が高く、細胞や臓器を用いた研究に積極的に取り組んでいる大学や学術機関が多数存在するため、2023年の同市場は最も高い収益を上げました。
• さらに、北米ではオルガノイドやスフェロイド培養製品の採用率が高く、効率的なヘルスケアインフラが整備されていることも、同地域の売上高が最も大きい要因となっています。
• アジア太平洋地域では、予測期間中に市場は有利な成長を遂げると予測されています。
• STEMCELL Technologies、Australasian Society for Stem Cell Research（ASSCR）、The Japanese Society for Regenerative Medicine、Korean Society for Stem Cell Research（KSSCR）などの主要企業や政府機関の存在が、アジアにおけるオルガノイドとスフェロイド培養の浸透を高めると予想されます。
• 主な企業は、市場での地位を高めるために、新製品の研究開発に絶えず取り組んでいます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 オルガノイドとスフェロイドの市場変数、動向および範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• オルガノイドとスフェロイド市場分析ツール
  • ポーターのファイブフォース分析
  • PESTEL分析
  • COVID-19感染症の影響分析

第4章 タイプビジネス分析

• セグメントダッシュボード
• 世界のオルガノイドとスフェロイド市場：型変動分析
• 世界のオルガノイドとスフェロイド市場規模と動向分析、タイプ別、2018年から2030年
• オルガノイド
  • 種類別のオルガノイド
  • 方法別オルガノイド
  • ソース別オルガノイド
• スフェロイド
  • タイプ別の回転楕円体
  • 方法別の回転楕円体
  • ソース別の回転楕円体

第5章 最終用途ビジネス分析

• セグメントダッシュボード
• 世界のオルガノイドとスフェロイド市場：最終用途の変動分析
• 世界のオルガノイドとスフェロイド市場規模と最終用途別の動向分析、2018年から2030年
• バイオテクノロジーと製薬産業
• 学術調査機関
• 病院と診断センター

第6章 アプリケーションビジネス分析

• セグメントダッシュボード
• 世界のオルガノイドとスフェロイド市場：アプリケーション変動分析
• 世界のオルガノイドとスフェロイド市場規模と動向分析、用途別、2018年から2030年
• 発生生物学
  • 発生生物学市場推計・予測と2018年から2030年まで
• 個別化医療
  • 個別化医療市場推計・予測
• 再生医療
  • 2018年から2030年までの再生医療市場推計・予測
• 疾患病理学研究
  • 疾患病理学研究市場推計・予測と2018年から2030年まで
• 薬物毒性および薬効試験
  • 2018年から2030年までの薬物毒性および有効性検査市場推計・予測

第7章 国、タイプ、用途、および最終用途別の地域ビジネス分析

• セグメントダッシュボード
• 2018年から2030年の市場規模と予測および動向分析
• 北米
• 欧州
• アジア太平洋地域
• ラテンアメリカ
• 中東・アフリカ

第8章 競合情勢

• 企業の分類
• 戦略マッピング
• 企業の市況分析、2023年
• 企業プロファイル・一覧表
  • Thermo Fisher Scientific, Inc.
  • Merck KGaA
  • Lonza
  • 3D Biomatrix
  • 3D Biotek LLC
  • AMS Biotechnology（Europe）Limited
  • Cellesce Ltd
  • Corning Incorporated
  • Greiner Bio-One
  • Hubrecht Organoid Technology（HUB）
  • InSphero
  • Prellis Biologics
  • STEMCELL Technologies Inc.

List of Tables

• Table 1 List of Abbreviations
• Table 2 North America organoids and spheroids market, by type, 2018 - 2030 (USD Million)
• Table 3 North America organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
• Table 4 North America organoids and spheroids market, by application, 2018 - 2030 (USD Million)
• Table 5 North America organoids and spheroids market, by region, 2018 - 2030 (USD Million)
• Table 6 U.S. organoids and spheroids market, by type, 2018 - 2030 (USD Million)
• Table 7 U.S. organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
• Table 8 U.S. organoids and spheroids market, by application, 2018 - 2030 (USD Million)
• Table 9 Canada organoids and spheroids market, by type, 2018 - 2030 (USD Million)
• Table 10 Canada organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
• Table 11 Canada organoids and spheroids market, by application, 2018 - 2030 (USD Million)
• Table 12 Europe organoids and spheroids market, by type, 2018 - 2030 (USD Million)
• Table 13 Europe organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
• Table 14 Europe organoids and spheroids market, by application, 2018 - 2030 (USD Million)
• Table 15 Europe organoids and spheroids market, by region, 2018 - 2030 (USD Million)
• Table 16 Germany organoids and spheroids market, by type, 2018 - 2030 (USD Million)
• Table 17 Germany organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
• Table 18 Germany organoids and spheroids market, by application, 2018 - 2030 (USD Million)
• Table 19 UK organoids and spheroids market, by type, 2018 - 2030 (USD Million)
• Table 20 UK organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
• Table 21 UK organoids and spheroids market, by application, 2018 - 2030 (USD Million)
• Table 22 France organoids and spheroids market, by type, 2018 - 2030 (USD Million)
• Table 23 France organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
• Table 24 France organoids and spheroids market, by application, 2018 - 2030 (USD Million)
• Table 25 Italy organoids and spheroids market, by type, 2018 - 2030 (USD Million)
• Table 26 Italy organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
• Table 27 Italy organoids and spheroids market, by application, 2018 - 2030 (USD Million)
• Table 28 Spain organoids and spheroids market, by type, 2018 - 2030 (USD Million)
• Table 29 Spain organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
• Table 30 Spain organoids and spheroids market, by application, 2018 - 2030 (USD Million)
• Table 31 Sweden organoids and spheroids market, by type, 2018 - 2030 (USD Million)
• Table 32 Sweden organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
• Table 33 Sweden organoids and spheroids market, by application, 2018 - 2030 (USD Million)
• Table 34 Norway organoids and spheroids market, by type, 2018 - 2030 (USD Million)
• Table 35 Norway organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
• Table 36 Norway organoids and spheroids market, by application, 2018 - 2030 (USD Million)
• Table 37 Denmark organoids and spheroids market, by type, 2018 - 2030 (USD Million)
• Table 38 Denmark organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
• Table 39 Denmark organoids and spheroids market, by application, 2018 - 2030 (USD Million)
• Table 40 APAC organoids and spheroids market, by type, 2018 - 2030 (USD Million)
• Table 41 APAC organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
• Table 42 APAC organoids and spheroids market, by application, 2018 - 2030 (USD Million)
• Table 43 APAC organoids and spheroids market, by region, 2018 - 2030 (USD Million)
• Table 44 China organoids and spheroids market, by type, 2018 - 2030 (USD Million)
• Table 45 China organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
• Table 46 China organoids and spheroids market, by application, 2018 - 2030 (USD Million)
• Table 47 Japan organoids and spheroids market, by type, 2018 - 2030 (USD Million)
• Table 48 Japan organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
• Table 49 Japan organoids and spheroids market, by application, 2018 - 2030 (USD Million)
• Table 50 India organoids and spheroids market, by type, 2018 - 2030 (USD Million)
• Table 51 India organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
• Table 52 India organoids and spheroids market, by application, 2018 - 2030 (USD Million)
• Table 53 Thailand organoids and spheroids market, by type, 2018 - 2030 (USD Million)
• Table 54 Thailand organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
• Table 55 Thailand organoids and spheroids market, by application, 2018 - 2030 (USD Million)
• Table 56 South Korea organoids and spheroids market, by type, 2018 - 2030 (USD Million)
• Table 57 South Korea organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
• Table 58 South Korea organoids and spheroids market, by application, 2018 - 2030 (USD Million)
• Table 59 Australia organoids and spheroids market, by type, 2018 - 2030 (USD Million)
• Table 60 Australia organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
• Table 61 Australia organoids and spheroids market, by application, 2018 - 2030 (USD Million)
• Table 62 Latin America organoids and spheroids market, by type, 2018 - 2030 (USD Million)
• Table 63 Latin America organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
• Table 64 Latin America organoids and spheroids market, by application, 2018 - 2030 (USD Million)
• Table 65 Latin America organoids and spheroids market, by region, 2018 - 2030 (USD Million)
• Table 66 Brazil organoids and spheroids market, by type, 2018 - 2030 (USD Million)
• Table 67 Brazil organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
• Table 68 Brazil organoids and spheroids market, by application, 2018 - 2030 (USD Million)
• Table 69 Mexico organoids and spheroids market, by type, 2018 - 2030 (USD Million)
• Table 70 Mexico organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
• Table 71 Mexico organoids and spheroids market, by application, 2018 - 2030 (USD Million)
• Table 72 Argentina organoids and spheroids market, by type, 2018 - 2030 (USD Million)
• Table 73 Argentina organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
• Table 74 Argentina organoids and spheroids market, by application, 2018 - 2030 (USD Million)
• Table 75 Middle East and Africa organoids and spheroids market, by type, 2018 - 2030 (USD Million)
• Table 76 Middle East and Africa organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
• Table 77 Middle East and Africa organoids and spheroids market, by application, 2018 - 2030 (USD Million)
• Table 78 Middle East and Africa organoids and spheroids market, by region, 2018 - 2030 (USD Million)
• Table 79 South Africa organoids and spheroids market, by type, 2018 - 2030 (USD Million)
• Table 80 South Africa organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
• Table 81 South Africa organoids and spheroids market, by application, 2018 - 2030 (USD Million)
• Table 82 Saudi Arabia organoids and spheroids market, by type, 2018 - 2030 (USD Million)
• Table 83 Saudi Arabia organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
• Table 84 Saudi Arabia organoids and spheroids market, by application, 2018 - 2030 (USD Million)
• Table 85 UAE organoids and spheroids market, by type, 2018 - 2030 (USD Million)
• Table 86 UAE organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
• Table 87 UAE organoids and spheroids market, by application, 2018 - 2030 (USD Million)
• Table 88 Kuwait organoids and spheroids market, by type, 2018 - 2030 (USD Million)
• Table 89 Kuwait organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
• Table 90 Kuwait organoids and spheroids market, by application, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Market research approaches
• Fig. 5 Value-chain-based sizing & forecasting
• Fig. 6 QFD modeling for market share assessment
• Fig. 7 Market formulation & validation
• Fig. 8 Organoids and Spheroids: market outlook
• Fig. 9 Organoids and Spheroids competitive insights
• Fig. 10 Parent market outlook
• Fig. 11 Related/ancillary market outlook
• Fig. 12 Organoids and Spheroids market driver impact
• Fig. 13 Organoids and Spheroids market restraint impact
• Fig. 14 Organoids and Spheroids market strategic initiatives analysis
• Fig. 15 Organoids and Spheroids market: type movement analysis
• Fig. 16 Organoids and Spheroids market: type outlook and key takeaways
• Fig. 17 Neural organoids market estimates and forecast, 2018 - 2030
• Fig. 18 Hepatic organoids market estimates and forecast, 2018 - 2030
• Fig. 19 Intestinal organoids market estimates and forecast, 2018 - 2030
• Fig. 20 Other organoids market estimates and forecast, 2018 - 2030
• Fig. 21 General submerged method for organoid culture market estimates and forecast, 2018 - 2030
• Fig. 22 Crypt organoid culture techniques market estimates and forecast, 2018 - 2030
• Fig. 23 ALI method for organoid culture market estimates and forecast, 2018 - 2030
• Fig. 24 Clonal Organoids from Lgr5+ Cells market estimates and forecast, 2018 - 2030
• Fig. 25 Brain and Retina Organoid Formation Protocol market estimates and forecast, 2018 - 2030
• Fig. 26 Others Organoid Formation Protocol market estimates and forecast, 2018 - 2030
• Fig. 27 Primary tissues market estimates and forecast, 2018 - 2030
• Fig. 28 Stem cells market estimates and forecast, 2018 - 2030
• Fig. 29 Spheroids market estimates and forecast, 2018 - 2030
• Fig. 30 MCTS market estimates and forecast, 2018 - 2030
• Fig. 31 Neurospheres market estimates and forecast, 2018 - 2030
• Fig. 32 Mammospheres market estimates and forecast, 2018 - 2030
• Fig. 33 Hepatospheres market estimates and forecast, 2018 - 2030
• Fig. 34 Embryoid bodies market estimates and forecast, 2018 - 2030
• Fig. 35 Micropatterned plates market estimates and forecast, 2018 - 2030
• Fig. 36 Low cell attachment plates market estimates and forecast, 2018 - 2030
• Fig. 37 Hanging drop method for spheroid culture market estimates and forecast, 2018 - 2030
• Fig. 38 Other methods for spheroid culture market estimates and forecast, 2018 - 2030
• Fig. 39 Cell line market estimates and forecast, 2018 - 2030
• Fig. 40 Primary cell market estimates and forecast, 2018 - 2030
• Fig. 41 iPSCs derived cells market estimates and forecast, 2018 - 2030
• Fig. 42 Organoids and spheroids market: end-use movement analysis
• Fig. 43 Organoids and spheroids market: end-use outlook and key takeaways
• Fig. 44 Biotechnology and pharmaceutical industries market estimates and forecast, 2018 - 2030
• Fig. 45 Academic & research institutes market estimates and forecast, 2018 - 2030
• Fig. 46 Hospitals and diagnostic centers market estimates and forecast, 2018 - 2030
• Fig. 47 Organoids and spheroids market: application movement analysis
• Fig. 48 Organoids and spheroids market: application outlook and key takeaways
• Fig. 49 Developmental biology market estimates and forecast, 2018 - 2030
• Fig. 50 Personalized medicine market estimates and forecast, 2018 - 2030
• Fig. 51 Regenerative medicine market estimates and forecast, 2018 - 2030
• Fig. 52 Disease pathology studies market estimates and forecast, 2018 - 2030
• Fig. 53 Drug toxicity & efficacy testing market estimates and forecast, 2018 - 2030
• Fig. 54 Global Organoids and spheroids market: regional movement analysis
• Fig. 55 Global Organoids and spheroids market: regional outlook and key takeaways
• Fig. 56 North America
• Fig. 57 North America market estimates and forecast, 2018 - 2030
• Fig. 58 U.S. key country dynamics
• Fig. 59 U.S. market estimates and forecast, 2018 - 2030
• Fig. 60 Canada key country dynamics
• Fig. 61 Canada market estimates and forecast, 2018 - 2030
• Fig. 62 Europe
• Fig. 63 Europe. market estimates and forecast, 2018 - 2030
• Fig. 64 UK key country dynamics
• Fig. 65 UK market estimates and forecast, 2018 - 2030
• Fig. 66 Germany key country dynamics
• Fig. 67 Germany market estimates and forecast, 2018 - 2030
• Fig. 68 France key country dynamics
• Fig. 69 France market estimates and forecast, 2018 - 2030
• Fig. 70 Italy key country dynamics
• Fig. 71 Italy market estimates and forecast, 2018 - 2030
• Fig. 72 Spain key country dynamics
• Fig. 73 Spain market estimates and forecast, 2018 - 2030
• Fig. 74 Sweden key country dynamics
• Fig. 75 Sweden market estimates and forecast, 2018 - 2030
• Fig. 76 Norway key country dynamics
• Fig. 77 Norway market estimates and forecast, 2018 - 2030
• Fig. 78 Denmark key country dynamics
• Fig. 79 Denmark market estimates and forecast, 2018 - 2030
• Fig. 80 Asia Pacific
• Fig. 81 Asia Pacific market estimates and forecast, 2018 - 2030
• Fig. 82 China key country dynamics
• Fig. 83 China market estimates and forecast, 2018 - 2030
• Fig. 84 Japan key country dynamics
• Fig. 85 Japan market estimates and forecast, 2018 - 2030
• Fig. 86 India key country dynamics
• Fig. 87 India market estimates and forecast, 2018 - 2030
• Fig. 88 Australia key country dynamics
• Fig. 89 Australia market estimates and forecast, 2018 - 2030
• Fig. 90 Thailand key country dynamics
• Fig. 91 Thailand market estimates and forecast, 2018 - 2030
• Fig. 92 South Korea key country dynamics
• Fig. 93 South Korea market estimates and forecast, 2018 - 2030
• Fig. 94 Latin America
• Fig. 95 Latin America market estimates and forecast, 2018 - 2030
• Fig. 96 Brazil key country dynamics
• Fig. 97 Brazil market estimates and forecast, 2018 - 2030
• Fig. 98 Mexico key country dynamics
• Fig. 99 Mexico market estimates and forecast, 2018 - 2030
• Fig. 100 Argentina key country dynamics
• Fig. 101 Argentina market estimates and forecast, 2018 - 2030
• Fig. 102 Middle East and Africa
• Fig. 103 Middle East and Africa. market estimates and forecast, 2018 - 2030
• Fig. 104 Saudi Arabia key country dynamics
• Fig. 105 Saudi Arabia market estimates and forecast, 2018 - 2030
• Fig. 106 South Africa key country dynamics
• Fig. 107 South Africa market estimates and forecast, 2018 - 2030
• Fig. 108 UAE key country dynamics
• Fig. 109 UAE market estimates and forecast, 2018 - 2030
• Fig. 110 Kuwait key country dynamics
• Fig. 111 Kuwait market estimates and forecast, 2018 - 2030

Organoids And Spheroids Market Growth & Trends:

The global organoids and spheroids market size is expected to reach USD 3.26 billion by 2030, registering a CAGR of 23.11% during the forecast period, according to a new report by Grand View Research, Inc., A rise in the adoption of organoid cultures in drug discovery, and rising demand for cell therapy and tissue engineering across the globe is expected to drive the market.

3D spheroids are considered as an important aspect of tissue engineering and regenerative medicine research as they can be used as building blocks for the generation of complex tissues and organs. In addition, the potential of 3D cell cultures to be used as models for drug screening and analysis of human disorders are expected to provide ample growth opportunities to the market in the near future.

A rise in the adoption of organoid cultures for the assessment of the mechanism of human-specific disorders is expected to enhance the market growth. For instance, human organoids have helped in the analysis of a wide range of tissues including the small intestine, prostate, brain, and liver. The promise of the generation of 3D cell cultures that resemble human organs has brought an enormous potential for the use of organoids as cell therapies, and as prospective substitutes for whole-organ transplantation.

Organoids And Spheroids Market Report Highlights:

• The spheroids segment is anticipated to dominate the market throughout the analysis period
• Higher adoption of 3D spheroids in the fields of drug discovery, disease modeling, and safety testing is a key factor driving the segment
• The developmental biology application segment accounted for the largest revenue share in 2023 as the development of organoids from Induced Pluripotent Stem Cells (iPSCs) have paved way for dynamic observation of cell development and propelled the adoption of mechanistic studies for human development
• Biotechnology and pharmaceutical industries dominated the end-use segment in the market in 2023. This is because of the high utilization rate of organoids and spheroids in pre-clinical drug discovery by pharma entities
• In addition, these players are actively involved in the development of advanced products that enhance the efficiency of organoid and spheroid generation.
• In North America, the market generated the highest revenue in 2023 due to higher adoption of technologically advanced cell culture platforms, and the presence of a large number of universities and academic institutions actively involved in cell and organ-based studies
• In addition, a higher adoption rate of organoid and spheroid culture products and efficient healthcare infrastructure in North America is attributive to the largest revenue generation from the region
• In Asia Pacific, the market is anticipated to witness lucrative growth over the forecast period.
• Presence of key players and government organizations such as STEMCELL Technologies, Australasian Society for Stem Cell Research (ASSCR), The Japanese Society for Regenerative Medicine, The Korean Society for Stem Cell Research (KSSCR), and others are expected to enhance the penetration of organoid and spheroid culture in Asia
• The key players are constantly involved in research and development of new products so that they can enhance their market position

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Type
  • 1.1.2. Application
  • 1.1.3. End-Use
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Organoids & Spheroids Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. High adoption of organoids & spheroids in drug discovery
    • 3.2.1.2. Technological advancements
    • 3.2.1.3. Rising demand for tissue engineering & organ transplantation
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Challenges associated with 3D cell culturing
    • 3.2.2.2. Ethical issues associated with organoid & spheroid cultures
• 3.3. Organoids & Spheroids Market Analysis Tools
  • 3.3.1. Porter's Five Forces Analysis
  • 3.3.2. PESTEL Analysis
  • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Type Business Analysis

• 4.1. Segment Dashboard
• 4.2. Global Organoids & Spheroids Market: Type Movement Analysis
• 4.3. Global Organoids & Spheroids Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
• 4.4. Organoids
  • 4.4.1. Organoids market estimates and forecast, 2018 - 2030
  • 4.4.2. Organoids by Type
    • 4.4.2.1. Neural Organoids
    • 4.4.2.1.1. Neural organoids market estimates and forecast, 2018 - 2030
    • 4.4.2.2. Hepatic Organoids
    • 4.4.2.2.1. Hepatic organoids market estimates and forecast, 2018 - 2030
    • 4.4.2.3. Intestinal organoids
    • 4.4.2.3.1. Intestinal organoids market estimates and forecast, 2018 - 2030
    • 4.4.2.4. Other organoids
    • 4.4.2.4.1. Other organoids market estimates and forecast, 2018 - 2030
  • 4.4.3. Organoids by Method
    • 4.4.3.1. General Submerged Method for Organoid Culture
    • 4.4.3.1.1. General Submerged Method for Organoid Culture market estimates and forecast, 2018 - 2030
    • 4.4.3.2. Crypt Organoid Culture Techniques
    • 4.4.3.2.1. Crypt Organoid Culture Techniques market estimates and forecast, 2018 - 2030
    • 4.4.3.3. Air Liquid Interface (ALI) Method for Organoid Culture
    • 4.4.3.3.1. ALI Method for Organoid Culture market estimates and forecast, 2018 - 2030
    • 4.4.3.4. Clonal Organoids from Lgr5+ Cells
    • 4.4.3.4.1. Clonal Organoids from Lgr5+ Cells market estimates and forecast, 2018 - 2030
    • 4.4.3.5. Brain and Retina Organoid Formation Protocol
    • 4.4.3.5.1. Brain and Retina Organoid Formation Protocol market estimates and forecast, 2018 - 2030
    • 4.4.3.6. Others
    • 4.4.3.6.1. Others market estimates and forecast, 2018 - 2030
  • 4.4.4. Organoids by Source
    • 4.4.4.1. Primary Tissues
    • 4.4.4.1.1. Primary tissues market estimates and forecast, 2018 - 2030
    • 4.4.4.2. Stem Cells
    • 4.4.4.2.1. Stem cells market estimates and forecast, 2018 - 2030
• 4.5. Spheroids
  • 4.5.1. Spheroids market estimates and forecast, 2018 - 2030
  • 4.5.2. Spheroids by Type
    • 4.5.2.1. Multicellular tumor spheroids (MCTS)
    • 4.5.2.1.1. MCTS market estimates and forecast, 2018 - 2030
    • 4.5.2.2. Neurospheres
    • 4.5.2.2.1. Neurospheres market estimates and forecast, 2018 - 2030
    • 4.5.2.3. Mammospheres
    • 4.5.2.3.1. Mammospheres market estimates and forecast, 2018 - 2030
    • 4.5.2.4. Hepatospheres
    • 4.5.2.4.1. Hepatospheres market estimates and forecast, 2018 - 2030
    • 4.5.2.5. Embryoid bodies
    • 4.5.2.5.1. Embryoid bodies market estimates and forecast, 2018 - 2030
  • 4.5.3. Spheroids by Method
    • 4.5.3.1. Micropatterned Plates
    • 4.5.3.1.1. Micropatterned Plates market estimates and forecast, 2018 - 2030
    • 4.5.3.2. Low Cell Attachment Plates
    • 4.5.3.2.1. Low Cell Attachment Plates market estimates and forecast, 2018 - 2030
    • 4.5.3.3. Hanging Drop Method
    • 4.5.3.3.1. Hanging Drop Method for spheroid Culture market estimates and forecast, 2018 - 2030
    • 4.5.3.4. Others
    • 4.5.3.4.1. Other methods for spheroid culture market estimates and forecast, 2018 - 2030
  • 4.5.4. Spheroids by Source
    • 4.5.4.1. Cell Line
    • 4.5.4.1.1. Cell line market estimates and forecast, 2018 - 2030
    • 4.5.4.2. Primary Cell
    • 4.5.4.2.1. Primary cell market estimates and forecast, 2018 - 2030
    • 4.5.4.3. iPSCs Derived Cells
    • 4.5.4.3.1. iPSCs Derived Cells market estimates and forecast, 2018 - 2030

Chapter 5. End-Use Business Analysis

• 5.1. Segment Dashboard
• 5.2. Global Organoids & Spheroids Market: End Use Movement Analysis
• 5.3. Global Organoids & Spheroids Market Size & Trend Analysis, by End-use, 2018 to 2030 (USD Million)
• 5.4. Biotechnology and Pharmaceutical Industries
  • 5.4.1. Biotechnology and Pharmaceutical Industries market estimates and forecast 2018 to 2030 (USD million)
• 5.5. Academic & Research Institutes
  • 5.5.1. Academic & Research Institutes market estimates and forecast 2018 to 2030 (USD Million)
• 5.6. Hospitals and Diagnostic Centers
  • 5.6.1. Hospitals and Diagnostic Centers market estimates and forecast 2018 to 2030 (USD million)

Chapter 6. Application Business Analysis

• 6.1. Segment Dashboard
• 6.2. Global Organoids & Spheroids Market: Application Movement Analysis
• 6.3. Global Organoids & Spheroids Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 6.4. Developmental Biology
  • 6.4.1. Developmental Biology market estimates and forecast 2018 to 2030 (USD million)
• 6.5. Personalized Medicine
  • 6.5.1. Personalized Medicine market estimates and forecast 2018 to 2030 (USD Million)
• 6.6. Regenerative Medicine
  • 6.6.1. Regenerative Medicine market estimates and forecast 2018 to 2030 (USD million)
• 6.7. Disease Pathology Studies
  • 6.7.1. Disease Pathology Studies market estimates and forecast 2018 to 2030 (USD Million)
• 6.8. Drug Toxicity & Efficacy Testing
  • 6.8.1. Drug Toxicity & Efficacy Testing market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. Regional Business Analysis, by Country, Type, Application, & End-use

• 7.1. Segment Dashboard
• 7.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
• 7.3. North America
  • 7.3.1. North America Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 7.3.2. U.S.
    • 7.3.2.1. Key Country Dynamics
    • 7.3.2.2. Target Disease Prevalence
    • 7.3.2.3. Competitive Scenario
    • 7.3.2.4. U.S. Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 7.3.3. Canada
    • 7.3.3.1. Key Country Dynamics
    • 7.3.3.2. Target Disease Prevalence
    • 7.3.3.3. Competitive Scenario
    • 7.3.3.4. Canada Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
• 7.4. Europe
  • 7.4.1. Europe Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 7.4.2. UK
    • 7.4.2.1. Key Country Dynamics
    • 7.4.2.2. Target Disease Prevalence
    • 7.4.2.3. Competitive Scenario
    • 7.4.2.4. UK Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 7.4.3. Germany
    • 7.4.3.1. Key Country Dynamics
    • 7.4.3.2. Target Disease Prevalence
    • 7.4.3.3. Competitive Scenario
    • 7.4.3.4. Germany Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 7.4.4. France
    • 7.4.4.1. Key Country Dynamics
    • 7.4.4.2. Target Disease Prevalence
    • 7.4.4.3. Competitive Scenario
    • 7.4.4.4. France Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 7.4.5. Italy
    • 7.4.5.1. Key Country Dynamics
    • 7.4.5.2. Target Disease Prevalence
    • 7.4.5.3. Competitive Scenario
    • 7.4.5.4. Italy Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 7.4.6. Spain
    • 7.4.6.1. Key Country Dynamics
    • 7.4.6.2. Target Disease Prevalence
    • 7.4.6.3. Competitive Scenario
    • 7.4.6.4. Spain Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 7.4.7. Denmark
    • 7.4.7.1. Key Country Dynamics
    • 7.4.7.2. Target Disease Prevalence
    • 7.4.7.3. Competitive Scenario
    • 7.4.7.4. Denmark Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 7.4.8. Sweden
    • 7.4.8.1. Key Country Dynamics
    • 7.4.8.2. Target Disease Prevalence
    • 7.4.8.3. Competitive Scenario
    • 7.4.8.4. Sweden Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 7.4.9. Norway
    • 7.4.9.1. Key Country Dynamics
    • 7.4.9.2. Target Disease Prevalence
    • 7.4.9.3. Competitive Scenario
    • 7.4.9.4. Norway Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
• 7.5. Asia Pacific
  • 7.5.1. Asia Pacific Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 7.5.2. China
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Target Disease Prevalence
    • 7.5.2.3. Competitive Scenario
    • 7.5.2.4. China Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 7.5.3. Japan
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Target Disease Prevalence
    • 7.5.3.3. Competitive Scenario
    • 7.5.3.4. Japan Market estimates and forecast, 2018 - 2030 (Volume, Thousand)
  • 7.5.4. India
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Target Disease Prevalence
    • 7.5.4.3. Competitive Scenario
    • 7.5.4.4. India Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 7.5.5. Australia
    • 7.5.5.1. Key Country Dynamics
    • 7.5.5.2. Target Disease Prevalence
    • 7.5.5.3. Competitive Scenario
    • 7.5.5.4. Australia Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 7.5.6. Thailand
    • 7.5.6.1. Key Country Dynamics
    • 7.5.6.2. Target Disease Prevalence
    • 7.5.6.3. Competitive Scenario
    • 7.5.6.4. Thailand Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 7.5.7. South Korea
    • 7.5.7.1. Key Country Dynamics
    • 7.5.7.2. Target Disease Prevalence
    • 7.5.7.3. Competitive Scenario
    • 7.5.7.4. South Korea Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
• 7.6. Latin America
  • 7.6.1. Latin America Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 7.6.2. Brazil
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Target Disease Prevalence
    • 7.6.2.3. Competitive Scenario
    • 7.6.2.4. Brazil Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 7.6.3. Mexico
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Target Disease Prevalence
    • 7.6.3.3. Competitive Scenario
    • 7.6.3.4. Mexico Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 7.6.4. Argentina
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Target Disease Prevalence
    • 7.6.4.3. Competitive Scenario
    • 7.6.4.4. Argentina Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
• 7.7. MEA
  • 7.7.1. MEA Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 7.7.2. Saudi Arabia
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Target Disease Prevalence
    • 7.7.2.3. Competitive Scenario
    • 7.7.2.4. Saudi Arabia Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 7.7.3. South Africa
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Target Disease Prevalence
    • 7.7.3.3. Competitive Scenario
    • 7.7.3.4. South Africa Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 7.7.4. UAE
    • 7.7.4.1. Key Country Dynamics
    • 7.7.4.2. Target Disease Prevalence
    • 7.7.4.3. Competitive Scenario
    • 7.7.4.4. UAE Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 7.7.5. Kuwait
    • 7.7.5.1. Key Country Dynamics
    • 7.7.5.2. Target Disease Prevalence
    • 7.7.5.3. Competitive Scenario
    • 7.7.5.4. Kuwait Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)

Chapter 8. Competitive Landscape

• 8.1. Company Categorization
• 8.2. Strategy Mapping
• 8.3. Company Market Position Analysis, 2023
• 8.4. Company Profiles/Listing
  • 8.4.1. Thermo Fisher Scientific, Inc.
    • 8.4.1.1. Company overview
    • 8.4.1.2. Financial performance
    • 8.4.1.3. Product benchmarking
    • 8.4.1.4. Strategic initiatives
  • 8.4.2. Merck KGaA
    • 8.4.2.1. Company overview
    • 8.4.2.2. Financial performance
    • 8.4.2.3. Product benchmarking
    • 8.4.2.4. Strategic initiatives
  • 8.4.3. Lonza
    • 8.4.3.1. Company overview
    • 8.4.3.2. Financial performance
    • 8.4.3.3. Product benchmarking
    • 8.4.3.4. Strategic initiatives
  • 8.4.4. 3D Biomatrix
    • 8.4.4.1. Company overview
    • 8.4.4.2. Financial performance
    • 8.4.4.3. Product benchmarking
    • 8.4.4.4. Strategic initiatives
  • 8.4.5. 3D Biotek LLC
    • 8.4.5.1. Company overview
    • 8.4.5.2. Financial performance
    • 8.4.5.3. Product benchmarking
    • 8.4.5.4. Strategic initiatives
  • 8.4.6. AMS Biotechnology (Europe) Limited
    • 8.4.6.1. Company overview
    • 8.4.6.2. Financial performance
    • 8.4.6.3. Product benchmarking
    • 8.4.6.4. Strategic initiatives
  • 8.4.7. Cellesce Ltd
    • 8.4.7.1. Company overview
    • 8.4.7.2. Financial performance
    • 8.4.7.3. Product benchmarking
    • 8.4.7.4. Strategic initiatives
  • 8.4.8. Corning Incorporated
    • 8.4.8.1. Company overview
    • 8.4.8.2. Financial performance
    • 8.4.8.3. Product benchmarking
    • 8.4.8.4. Strategic initiatives
  • 8.4.9. Greiner Bio-One
    • 8.4.9.1. Company overview
    • 8.4.9.2. Financial performance
    • 8.4.9.3. Product benchmarking
    • 8.4.9.4. Strategic initiatives
  • 8.4.10. Hubrecht Organoid Technology (HUB)
    • 8.4.10.1. Company overview
    • 8.4.10.2. Financial performance
    • 8.4.10.3. Product benchmarking
    • 8.4.10.4. Strategic initiatives
  • 8.4.11. InSphero
    • 8.4.11.1. Company overview
    • 8.4.11.2. Financial performance
    • 8.4.11.3. Product benchmarking
    • 8.4.11.4. Strategic initiatives
  • 8.4.12. Prellis Biologics
    • 8.4.12.1. Company overview
    • 8.4.12.2. Financial performance
    • 8.4.12.3. Product benchmarking
    • 8.4.12.4. Strategic initiatives
  • 8.4.13. STEMCELL Technologies Inc.
    • 8.4.13.1. Company overview
    • 8.4.13.2. Financial performance
    • 8.4.13.3. Product benchmarking
    • 8.4.13.4. Strategic initiatives